-
1
-
-
84864598311
-
Long-term survival and recurrence after acute myocardial infarction in England 2004 to 2010
-
Smolina K, Wright FL, Rayner M et al. Long-term survival and recurrence after acute myocardial infarction in England, 2004 to 2010. Circ. Cardiovasc. Qual. Outcomes 5(4), 532-540 (2012).
-
(2012)
Circ. Cardiovasc. Qual. Outcomes
, vol.5
, Issue.4
, pp. 532-540
-
-
Smolina, K.1
Wright, F.L.2
Rayner, M.3
-
2
-
-
84867362492
-
Third universal definition of myocardial infarction
-
Thygesen K, Alpert JS, Jaffe AS et al. Third universal definition of myocardial infarction. J. Am. Coll. Cardiol. 60(16), 1581-1598 (2012).
-
(2012)
J. Am. Coll. Cardiol.
, vol.60
, Issue.16
, pp. 1581-1598
-
-
Thygesen, K.1
Alpert, J.S.2
Jaffe, A.S.3
-
3
-
-
84875170063
-
Translating cardioprotection for patient benefit: Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology
-
Hausenloy DJ, Erik BH, Condorelli G et al. Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc. Res. 98(1), 7-27 (2013).
-
(2013)
Cardiovasc. Res.
, vol.98
, Issue.1
, pp. 7-27
-
-
Hausenloy, D.J.1
Erik, B.H.2
Condorelli, G.3
-
5
-
-
84891706291
-
Mechanisms of disease: Is mitochondrial function altered in heart failure
-
Hamilton DJ. Mechanisms of disease: is mitochondrial function altered in heart failure Methodist Debakey Cardiovasc J. 9(1), 44-48 (2013).
-
(2013)
Methodist Debakey Cardiovasc J.
, vol.9
, Issue.1
, pp. 44-48
-
-
Hamilton, D.J.1
-
6
-
-
84867691699
-
Mitochondrial control of cellular life, stress, and death
-
Galluzzi L, Kepp O, Trojel-Hansen C et al. Mitochondrial control of cellular life, stress, and death. Circ. Res. 111(9), 1198-1207 (2012).
-
(2012)
Circ. Res.
, vol.111
, Issue.9
, pp. 1198-1207
-
-
Galluzzi, L.1
Kepp, O.2
Trojel-Hansen, C.3
-
7
-
-
84875068490
-
Targeting mitochondrial oxidative metabolism as an approach to treat heart failure
-
Fillmore N, Lopaschuk GD. Targeting mitochondrial oxidative metabolism as an approach to treat heart failure. Biochim. Biophys. Acta 1833(4), 857-865 (2013).
-
(2013)
Biochim. Biophys. Acta
, vol.1833
, Issue.4
, pp. 857-865
-
-
Fillmore, N.1
Lopaschuk, G.D.2
-
9
-
-
84862908305
-
Cardiomyocyte death: Mechanisms and translational implications
-
Chiong M, Wang ZV, Pedrozo Z et al. Cardiomyocyte death: mechanisms and translational implications. Cell Death Dis. 2, e244 (2011).
-
(2011)
Cell Death Dis.
, vol.2
-
-
Chiong, M.1
Wang, Z.V.2
Pedrozo, Z.3
-
10
-
-
84873848690
-
Myocardial ischemia-reperfusion injury: A neglected therapeutic target
-
Hausenloy DJ, Yellon DM. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J. Clin. Invest. 123(1), 92-100 (2013).
-
(2013)
J. Clin. Invest.
, vol.123
, Issue.1
, pp. 92-100
-
-
Hausenloy, D.J.1
Yellon, D.M.2
-
11
-
-
80051506119
-
Cell death pathways in acute ischemia/reperfusion injury
-
Gottlieb RA. Cell death pathways in acute ischemia/reperfusion injury. J. Cardiovasc. Pharmacol. Ther. 16(3-4), 233-238 (2011).
-
(2011)
J. Cardiovasc. Pharmacol. Ther.
, vol.16
, Issue.3-4
, pp. 233-238
-
-
Gottlieb, R.A.1
-
12
-
-
62249162170
-
The mitochondrial permeability transition pore and ischemia-reperfusion injury
-
Baines CP. The mitochondrial permeability transition pore and ischemia-reperfusion injury. Basic Res. Cardiol. 104(2), 181-188 (2009).
-
(2009)
Basic Res. Cardiol.
, vol.104
, Issue.2
, pp. 181-188
-
-
Baines, C.P.1
-
13
-
-
67349164763
-
A CaPful of mechanisms regulating the mitochondrial permeability transition
-
Di Lisa F, Bernardi P. A CaPful of mechanisms regulating the mitochondrial permeability transition. J. Mol. Cell. Cardiol. 46(6), 775-780 (2009).
-
(2009)
J. Mol. Cell. Cardiol.
, vol.46
, Issue.6
, pp. 775-780
-
-
Di Lisa, F.1
Bernardi, P.2
-
14
-
-
84870278725
-
Mitochondrial membrane permeabilization and cell death during myocardial infarction: Roles of calcium and reactive oxygen species
-
Webster KA. Mitochondrial membrane permeabilization and cell death during myocardial infarction: roles of calcium and reactive oxygen species. Future Cardiol. 8(6), 863-884 (2012).
-
(2012)
Future Cardiol.
, vol.8
, Issue.6
, pp. 863-884
-
-
Webster, K.A.1
-
15
-
-
84877011174
-
Targeting cell death in the reperfused heart: Pharmacological approaches for cardioprotection
-
Oerlemans MI, Koudstaal S, Chamuleau SA et al. Targeting cell death in the reperfused heart: pharmacological approaches for cardioprotection. Int. J. Cardiol. 165(3), 410-422 (2013).
-
(2013)
Int. J. Cardiol.
, vol.165
, Issue.3
, pp. 410-422
-
-
Oerlemans, M.I.1
Koudstaal, S.2
Chamuleau, S.A.3
-
16
-
-
33644840693
-
Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury
-
Degterev A, Huang Z, Boyce M et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat. Chem. Biol. 1(2), 112-119 (2005).
-
(2005)
Nat. Chem. Biol.
, vol.1
, Issue.2
, pp. 112-119
-
-
Degterev, A.1
Huang, Z.2
Boyce, M.3
-
17
-
-
80052173847
-
Necroptosis, necrostatins and tissue injury
-
Smith CC, Yellon DM. Necroptosis, necrostatins and tissue injury. J. Cell. Mol. Med. 15(9), 1797-1806 (2011).
-
(2011)
J. Cell. Mol. Med.
, vol.15
, Issue.9
, pp. 1797-1806
-
-
Smith, C.C.1
Yellon, D.M.2
-
18
-
-
62249102192
-
The mitochondrial permeability transition pore as a target for preconditioning and postconditioning
-
Hausenloy DJ, Ong SB, Yellon DM. The mitochondrial permeability transition pore as a target for preconditioning and postconditioning. Basic Res. Cardiol. 104(2), 189-202 (2009).
-
(2009)
Basic Res. Cardiol.
, vol.104
, Issue.2
, pp. 189-202
-
-
Hausenloy, D.J.1
Ong, S.B.2
Yellon, D.M.3
-
19
-
-
84881342113
-
Cardioprotection techniques: Preconditioning, postconditioning and remote conditioning (basic science)
-
Hausenloy DJ. Cardioprotection techniques: preconditioning, postconditioning and remote conditioning (basic science). Curr. Pharm. Des. 19(25), 4544-4563 (2013).
-
(2013)
Curr. Pharm. Des.
, vol.19
, Issue.25
, pp. 4544-4563
-
-
Hausenloy, D.J.1
-
20
-
-
34548044947
-
Preconditioning and postconditioning: United at reperfusion
-
Hausenloy DJ, Yellon DM. Preconditioning and postconditioning: united at reperfusion. Pharmacol. Ther. 116(2), 173-191 (2007).
-
(2007)
Pharmacol. Ther.
, vol.116
, Issue.2
, pp. 173-191
-
-
Hausenloy, D.J.1
Yellon, D.M.2
-
21
-
-
46849092968
-
Nitrate-induced toxicity and preconditioning: A rationale for reconsidering the use of these drugs
-
Gori T, Parker JD. Nitrate-induced toxicity and preconditioning: a rationale for reconsidering the use of these drugs. J. Am. Coll. Cardiol. 52(4), 251-254 (2008).
-
(2008)
J. Am. Coll. Cardiol.
, vol.52
, Issue.4
, pp. 251-254
-
-
Gori, T.1
Parker, J.D.2
-
22
-
-
0022970945
-
Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium
-
Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74(5), 1124-1136 (1986).
-
(1986)
Circulation
, vol.74
, Issue.5
, pp. 1124-1136
-
-
Murry, C.E.1
Jennings, R.B.2
Reimer, K.A.3
-
23
-
-
0141751749
-
Preconditioning the myocardium: From cellular physiology to clinical cardiology
-
Yellon DM, Downey JM. Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol. Rev. 83(4), 1113-1151 (2003).
-
(2003)
Physiol. Rev.
, vol.83
, Issue.4
, pp. 1113-1151
-
-
Yellon, D.M.1
Downey, J.M.2
-
24
-
-
80051509872
-
Commentary on selected aspects of cardioprotection
-
Jennings RB. Commentary on selected aspects of cardioprotection. J. Cardiovasc. Pharmacol. Ther. 16(3-4), 340-348 (2011).
-
(2011)
J. Cardiovasc. Pharmacol. Ther.
, vol.16
, Issue.3-4
, pp. 340-348
-
-
Jennings, R.B.1
-
25
-
-
0031002408
-
Ischaemic preconditioning reduces troponin T release in patients undergoing coronary artery bypass surgery
-
Jenkins DP, Pugsley WB, Alkhulaifi AM et al. Ischaemic preconditioning reduces troponin T release in patients undergoing coronary artery bypass surgery. Heart 77(4), 314-318 (1997).
-
(1997)
Heart
, vol.77
, Issue.4
, pp. 314-318
-
-
Jenkins, D.P.1
Pugsley, W.B.2
Alkhulaifi, A.M.3
-
26
-
-
0027301398
-
Preconditioning the human myocardium
-
Yellon DM, Alkhulaifi AM, Pugsley WB. Preconditioning the human myocardium. Lancet 342(8866), 276-277 (1993).
-
(1993)
Lancet
, vol.342
, Issue.8866
, pp. 276-277
-
-
Yellon, D.M.1
Alkhulaifi, A.M.2
Pugsley, W.B.3
-
27
-
-
38349054173
-
Effect of ischemic postconditioning in adult valve replacement
-
Luo W, Li B, Chen R et al. Effect of ischemic postconditioning in adult valve replacement. Eur. J. Cardiothorac. Surg. 33(2), 203-208 (2008).
-
(2008)
Eur. J. Cardiothorac. Surg.
, vol.33
, Issue.2
, pp. 203-208
-
-
Luo, W.1
Li, B.2
Chen, R.3
-
28
-
-
84864721500
-
The efficacies of modified mechanical post conditioning on myocardial protection for patients undergoing coronary artery bypass grafting
-
Durdu S, Sirlak M, Cetintas D et al. The efficacies of modified mechanical post conditioning on myocardial protection for patients undergoing coronary artery bypass grafting. J. Cardiothorac. Surg. 7, 73 (2012).
-
(2012)
J. Cardiothorac. Surg.
, vol.7
, Issue.73
-
-
Durdu, S.1
Sirlak, M.2
Cetintas, D.3
-
29
-
-
34848831837
-
Reduction in myocardial infarct size by postconditioning in patients after percutaneous coronary intervention
-
Yang XC, Liu Y, Wang LF et al. Reduction in myocardial infarct size by postconditioning in patients after percutaneous coronary intervention. J. Invasive Cardiol. 19(10), 424-430 (2007).
-
(2007)
J. Invasive Cardiol.
, vol.19
, Issue.10
, pp. 424-430
-
-
Yang, X.C.1
Liu, Y.2
Wang, L.F.3
-
30
-
-
40749130846
-
Long-term benefit of postconditioning
-
Thibault H, Piot C, Staat P et al. Long-term benefit of postconditioning. Circulation 117(8), 1037-1044 (2008).
-
(2008)
Circulation
, vol.117
, Issue.8
, pp. 1037-1044
-
-
Thibault, H.1
Piot, C.2
Staat, P.3
-
31
-
-
84862983669
-
Effect of postconditioning in patients with ST-elevation acute myocardial infarction
-
Ugata Y, Nakamura T, Taniguchi Y et al. Effect of postconditioning in patients with ST-elevation acute myocardial infarction. Cardiovasc. Interv. Ther. 27(1), 14-18 (2012).
-
(2012)
Cardiovasc. Interv. Ther.
, vol.27
, Issue.1
, pp. 14-18
-
-
Ugata, Y.1
Nakamura, T.2
Taniguchi, Y.3
-
32
-
-
78049281398
-
Effect of postconditioning on infarct size in patients with ST elevation myocardial infarction
-
Sorensson P, Saleh N, Bouvier F et al. Effect of postconditioning on infarct size in patients with ST elevation myocardial infarction. Heart 96(21), 1710-1715 (2010).
-
(2010)
Heart
, vol.96
, Issue.21
, pp. 1710-1715
-
-
Sorensson, P.1
Saleh, N.2
Bouvier, F.3
-
33
-
-
84875310813
-
Long-term impact of postconditioning on infarct size and left ventricular ejection fraction in patients with ST-elevation myocardial infarction
-
Sorensson P, Ryden L, Saleh N et al. Long-term impact of postconditioning on infarct size and left ventricular ejection fraction in patients with ST-elevation myocardial infarction. BMC Cardiovasc. Disord. 13, 22 (2013).
-
(2013)
BMC Cardiovasc. Disord.
, vol.13
, Issue.22
-
-
Sorensson, P.1
Ryden, L.2
Saleh, N.3
-
34
-
-
84870241753
-
Postconditioning during coronary angioplasty in acute myocardial infarction: The POST-AMI trial
-
Tarantini G, Favaretto E, Marra MP et al. Postconditioning during coronary angioplasty in acute myocardial infarction: the POST-AMI trial. Int. J. Cardiol. 162(1), 33-38 (2012).
-
(2012)
Int. J. Cardiol.
, vol.162
, Issue.1
, pp. 33-38
-
-
Tarantini, G.1
Favaretto, E.2
Marra, M.P.3
-
35
-
-
84855512864
-
Ischaemic postconditioning revisited: Lack of effects on infarct size following primary percutaneous coronary intervention
-
Freixa X, Bellera N, Ortiz-Perez JT et al. Ischaemic postconditioning revisited: lack of effects on infarct size following primary percutaneous coronary intervention. Eur. Heart J. 33(1), 103-112 (2012).
-
(2012)
Eur. Heart J.
, vol.33
, Issue.1
, pp. 103-112
-
-
Freixa, X.1
Bellera, N.2
Ortiz-Perez, J.T.3
-
36
-
-
33646932408
-
Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: First clinical application in humans
-
Cheung MM, Kharbanda RK, Konstantinov IE et al. Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: first clinical application in humans. J. Am. Coll. Cardiol. 47(11), 2277-2282 (2006).
-
(2006)
J. Am. Coll. Cardiol.
, vol.47
, Issue.11
, pp. 2277-2282
-
-
Cheung, M.M.1
Kharbanda, R.K.2
Konstantinov, I.E.3
-
37
-
-
34547837402
-
Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: A randomised controlled trial
-
Hausenloy DJ, Mwamure PK, Venugopal V et al. Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial. Lancet 370(9587), 575-579 (2007).
-
(2007)
Lancet
, vol.370
, Issue.9587
, pp. 575-579
-
-
Hausenloy, D.J.1
Mwamure, P.K.2
Venugopal, V.3
-
38
-
-
70349446441
-
Remote ischaemic preconditioning reduces myocardial injury in patients undergoing cardiac surgery with cold-blood cardioplegia: A randomised controlled trial
-
Venugopal V, Hausenloy DJ, Ludman A et al. Remote ischaemic preconditioning reduces myocardial injury in patients undergoing cardiac surgery with cold-blood cardioplegia: a randomised controlled trial. Heart 95(19), 1567-1571 (2009).
-
(2009)
Heart
, vol.95
, Issue.19
, pp. 1567-1571
-
-
Venugopal, V.1
Hausenloy, D.J.2
Ludman, A.3
-
39
-
-
77955866454
-
Induced remote ischemic pre-conditioning on ischemia-reperfusion injury in patients undergoing coronary artery bypass
-
Ali N, Rizwi F, Iqbal A et al. Induced remote ischemic pre-conditioning on ischemia-reperfusion injury in patients undergoing coronary artery bypass. J. Coll. Physicians Surg. Pak. 20(7), 427-431 (2010).
-
(2010)
J. Coll. Physicians Surg. Pak.
, vol.20
, Issue.7
, pp. 427-431
-
-
Ali, N.1
Rizwi, F.2
Iqbal, A.3
-
40
-
-
84882265326
-
Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: A single-centre randomised, double-blind, controlled trial
-
Thielmann M, Kottenberg E, Kleinbongard P et al. Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single-centre randomised, double-blind, controlled trial. Lancet 382(9892), 597-604 (2013).
-
(2013)
Lancet
, vol.382
, Issue.9892
, pp. 597-604
-
-
Thielmann, M.1
Kottenberg, E.2
Kleinbongard, P.3
-
41
-
-
74049108136
-
Cardioprotective role of remote ischemic periconditioning in primary percutaneous coronary intervention: Enhancement by opioid action
-
Rentoukas I, Giannopoulos G, Kaoukis A et al. Cardioprotective role of remote ischemic periconditioning in primary percutaneous coronary intervention: enhancement by opioid action. JACC Cardiovasc. Interv. 3(1), 49-55 (2010).
-
(2010)
JACC Cardiovasc. Interv.
, vol.3
, Issue.1
, pp. 49-55
-
-
Rentoukas, I.1
Giannopoulos, G.2
Kaoukis, A.3
-
42
-
-
77249107745
-
Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: A randomised trial
-
Botker HE, Kharbanda R, Schmidt MR et al. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet 375(9716), 727-734 (2010).
-
(2010)
Lancet
, vol.375
, Issue.9716
, pp. 727-734
-
-
Botker, H.E.1
Kharbanda, R.2
Schmidt, M.R.3
-
43
-
-
78650285662
-
Remote ischemic conditioning in patients with myocardial infarction treated with primary angioplasty: Impact on left ventricular function assessed by comprehensive echocardiography and gated single-photon emission CT
-
Munk K, Andersen NH, Schmidt MR et al. Remote ischemic conditioning in patients with myocardial infarction treated with primary angioplasty: impact on left ventricular function assessed by comprehensive echocardiography and gated single-photon emission CT. Circ. Cardiovasc. Imaging 3(6), 656-662 (2010).
-
(2010)
Circ. Cardiovasc. Imaging
, vol.3
, Issue.6
, pp. 656-662
-
-
Munk, K.1
Andersen, N.H.2
Schmidt, M.R.3
-
44
-
-
4043060632
-
Postconditioning: A form of modified reperfusion protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway
-
Tsang A, Hausenloy DJ, Mocanu MM et al. Postconditioning: a form of modified reperfusion protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. Circ. Res. 95(3), 230-232 (2004).
-
(2004)
Circ. Res.
, vol.95
, Issue.3
, pp. 230-232
-
-
Tsang, A.1
Hausenloy, D.J.2
Mocanu, M.M.3
-
45
-
-
12344317925
-
Postconditioning inhibits mitochondrial permeability transition
-
Argaud L, Gateau-Roesch O, Raisky O et al. Postconditioning inhibits mitochondrial permeability transition. Circulation 111(2), 194-197 (2005).
-
(2005)
Circulation
, vol.111
, Issue.2
, pp. 194-197
-
-
Argaud, L.1
Gateau-Roesch, O.2
Raisky, O.3
-
46
-
-
34447507839
-
Preconditioning and postconditioning: The essential role of the mitochondrial permeability transition pore
-
Lim SY, Davidson SM, Hausenloy DJ et al. Preconditioning and postconditioning: the essential role of the mitochondrial permeability transition pore. Cardiovasc. Res. 75(3), 530-535 (2007).
-
(2007)
Cardiovasc. Res.
, vol.75
, Issue.3
, pp. 530-535
-
-
Lim, S.Y.1
Davidson, S.M.2
Hausenloy, D.J.3
-
47
-
-
33645736864
-
Ischemic postconditioning during reperfusion activates Akt and ERK without protecting against lethal myocardial ischemia-reperfusion injury in pigs
-
Schwartz LM, Lagranha CJ. Ischemic postconditioning during reperfusion activates Akt and ERK without protecting against lethal myocardial ischemia-reperfusion injury in pigs. Am. J. Physiol. Heart Circ. Physiol. 290(3), H1011-H1018 (2006).
-
(2006)
Am. J. Physiol. Heart Circ. Physiol.
, vol.290
, Issue.3
-
-
Schwartz, L.M.1
Lagranha, C.J.2
-
48
-
-
34249693654
-
Postconditioning does not reduce myocardial infarct size in an in vivo regional ischemia rodent model
-
Dow J, Kloner RA. Postconditioning does not reduce myocardial infarct size in an in vivo regional ischemia rodent model. J. Cardiovasc. Pharmacol. Ther. 12(2), 153-163 (2007).
-
(2007)
J. Cardiovasc. Pharmacol. Ther.
, vol.12
, Issue.2
, pp. 153-163
-
-
Dow, J.1
Kloner, R.A.2
-
49
-
-
38149068092
-
Postconditioning fails to improve no reflow or alter infarct size in an open-chest rabbit model of myocardial ischemia-reperfusion
-
Hale SL, Mehra A, Leeka J et al. Postconditioning fails to improve no reflow or alter infarct size in an open-chest rabbit model of myocardial ischemia-reperfusion. Am. J. Physiol. Heart Circ. Physiol. 294(1), H421-H425 (2008).
-
(2008)
Am. J. Physiol. Heart Circ. Physiol.
, vol.294
, Issue.1
-
-
Hale, S.L.1
Mehra, A.2
Leeka, J.3
-
50
-
-
77953682356
-
Cardioprotective effects of ischemic postconditioning in patients treated with primary percutaneous coronary intervention, evaluated by magnetic resonance
-
Lonborg J, Kelbaek H, Vejlstrup N et al. Cardioprotective effects of ischemic postconditioning in patients treated with primary percutaneous coronary intervention, evaluated by magnetic resonance. Circ. Cardiovasc. Interv. 3(1), 34-41 (2010).
-
(2010)
Circ. Cardiovasc. Interv.
, vol.3
, Issue.1
, pp. 34-41
-
-
Lonborg, J.1
Kelbaek, H.2
Vejlstrup, N.3
-
51
-
-
77957863131
-
Postconditioning during primary percutaneous coronary intervention: A review and meta-analysis
-
Hansen PR, Thibault H, Abdulla J. Postconditioning during primary percutaneous coronary intervention: a review and meta-analysis. Int. J. Cardiol. 144(1), 22-25 (2010).
-
(2010)
Int. J. Cardiol.
, vol.144
, Issue.1
, pp. 22-25
-
-
Hansen, P.R.1
Thibault, H.2
Abdulla, J.3
-
52
-
-
84855474703
-
Reduction of infarct size by ischaemic post-conditioning in humans: Fact or fiction Eur
-
Heusch G. Reduction of infarct size by ischaemic post-conditioning in humans: fact or fiction Eur. Heart J. 33(1), 13-15 (2012).
-
(2012)
Heart J.
, vol.33
, Issue.1
, pp. 13-15
-
-
Heusch, G.1
-
53
-
-
80755125546
-
Myocardial postconditioning: Next step to cardioprotection
-
Rohilla A, Rohilla S, Kushnoor A. Myocardial postconditioning: next step to cardioprotection. Arch. Pharm. Res. 34(9), 1409-1415 (2011).
-
(2011)
Arch. Pharm. Res.
, vol.34
, Issue.9
, pp. 1409-1415
-
-
Rohilla, A.1
Rohilla, S.2
Kushnoor, A.3
-
54
-
-
84870293744
-
Local ischemic postconditioning during primary percutaneous coronary intervention: A meta-analysis
-
Wei Y, Ruan L, Zhou G et al. Local ischemic postconditioning during primary percutaneous coronary intervention: a meta-analysis. Cardiology 123(4), 225-233 (2012).
-
(2012)
Cardiology
, vol.123
, Issue.4
, pp. 225-233
-
-
Wei, Y.1
Ruan, L.2
Zhou, G.3
-
55
-
-
0027401466
-
Regional ischemic preconditioning protects remote virgin myocardium from subsequent sustained coronary occlusion
-
Przyklenk K, Bauer B, Ovize M et al. Regional ischemic preconditioning protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation 87(3), 893-899 (1993).
-
(1993)
Circulation
, vol.87
, Issue.3
, pp. 893-899
-
-
Przyklenk, K.1
Bauer, B.2
Ovize, M.3
-
56
-
-
0037016064
-
Transient limb ischemia induces remote ischemic preconditioning in vivo
-
Kharbanda RK, Mortensen UM, White PA et al. Transient limb ischemia induces remote ischemic preconditioning in vivo. Circulation 106(23), 2881-2883 (2002).
-
(2002)
Circulation
, vol.106
, Issue.23
, pp. 2881-2883
-
-
Kharbanda, R.K.1
Mortensen, U.M.2
White, P.A.3
-
57
-
-
34147172678
-
Intermittent peripheral tissue ischemia during coronary ischemia reduces myocardial infarction through a KATP-dependent mechanism: First demonstration of remote ischemic preconditioning
-
Schmidt MR, Smerup M, Konstantinov IE et al. Intermittent peripheral tissue ischemia during coronary ischemia reduces myocardial infarction through a KATP-dependent mechanism: first demonstration of remote ischemic perconditioning. Am. J. Physiol. Heart Circ. Physiol. 292(4), H1883-H1890 (2007).
-
(2007)
Am. J. Physiol. Heart Circ. Physiol.
, vol.292
, Issue.4
-
-
Schmidt, M.R.1
Smerup, M.2
Konstantinov, I.E.3
-
58
-
-
34249277833
-
Remote ischaemic postconditioning protects the heart during acute myocardial infarction in pigs
-
Andreka G, Vertesaljai M, Szantho G et al. Remote ischaemic postconditioning protects the heart during acute myocardial infarction in pigs. Heart 93(6), 749-752 (2007).
-
(2007)
Heart
, vol.93
, Issue.6
, pp. 749-752
-
-
Andreka, G.1
Vertesaljai, M.2
Szantho, G.3
-
59
-
-
84860837867
-
Effect of remote ischemic preconditioning on clinical outcomes in patients undergoing coronary artery bypass graft surgery (ERICCA): Rationale and study design of a multi-centre randomized double-blinded controlled clinical trial
-
Hausenloy DJ, Candilio L, Laing C et al. Effect of remote ischemic preconditioning on clinical outcomes in patients undergoing coronary artery bypass graft surgery (ERICCA): rationale and study design of a multi-centre randomized double-blinded controlled clinical trial. Clin. Res. Cardiol. 101(5), 339-348 (2012).
-
(2012)
Clin. Res. Cardiol.
, vol.101
, Issue.5
, pp. 339-348
-
-
Hausenloy, D.J.1
Candilio, L.2
Laing, C.3
-
60
-
-
84863601363
-
Remote ischaemic preconditioning for heart surgery. The study design for a multi-center randomized double-blinded controlled clinical trial-The RIPHeart-Study
-
Meybohm P, Zacharowski K, Cremer J et al. Remote ischaemic preconditioning for heart surgery. The study design for a multi-center randomized double-blinded controlled clinical trial-The RIPHeart-Study. Eur. Heart J. 33(12), 1423-1426 (2012).
-
(2012)
Eur. Heart J.
, vol.33
, Issue.12
, pp. 1423-1426
-
-
Meybohm, P.1
Zacharowski, K.2
Cremer, J.3
-
62
-
-
84857098116
-
Cyclosporin A and cardioprotection: From investigative tool to therapeutic agent
-
Hausenloy DJ, Boston-Griffiths EA, Yellon DM. Cyclosporin A and cardioprotection: from investigative tool to therapeutic agent. Br. J. Pharmacol. 165(5), 1235-1245 (2012).
-
(2012)
Br. J. Pharmacol.
, vol.165
, Issue.5
, pp. 1235-1245
-
-
Hausenloy, D.J.1
Boston-Griffiths, E.A.2
Yellon, D.M.3
-
63
-
-
0036023641
-
Inhibiting mitochondrial permeability transition pore opening: A new paradigm for myocardial preconditioning
-
Hausenloy DJ, Maddock HL, Baxter GF et al. Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning Cardiovasc. Res. 55(3), 534-543 (2002).
-
(2002)
Cardiovasc. Res.
, vol.55
, Issue.3
, pp. 534-543
-
-
Hausenloy, D.J.1
Maddock, H.L.2
Baxter, G.F.3
-
64
-
-
77951294419
-
Cyclosporine A at reperfusion reduces infarct size in pigs
-
Skyschally A, Schulz R, Heusch G. Cyclosporine A at reperfusion reduces infarct size in pigs. Cardiovasc. Drugs Ther. 24(1), 85-87 (2010).
-
(2010)
Cardiovasc. Drugs Ther.
, vol.24
, Issue.1
, pp. 85-87
-
-
Skyschally, A.1
Schulz, R.2
Heusch, G.3
-
65
-
-
13444282326
-
Specific inhibition of the mitochondrial permeability transition prevents lethal reperfusion injury
-
Argaud L, Gateau-Roesch O, Muntean D et al. Specific inhibition of the mitochondrial permeability transition prevents lethal reperfusion injury. J. Mol. Cell. Cardiol. 38(2), 367-374 (2005).
-
(2005)
J. Mol. Cell. Cardiol.
, vol.38
, Issue.2
, pp. 367-374
-
-
Argaud, L.1
Gateau-Roesch, O.2
Muntean, D.3
-
66
-
-
77951912363
-
Cyclosporine does not reduce myocardial infarct size in a porcine ischemia-reperfusion model
-
Karlsson LO, Zhou AX, Larsson E et al. Cyclosporine does not reduce myocardial infarct size in a porcine ischemia-reperfusion model. J. Cardiovasc. Pharmacol. Ther. 15(2), 182-189 (2010).
-
(2010)
J. Cardiovasc. Pharmacol. Ther.
, vol.15
, Issue.2
, pp. 182-189
-
-
Karlsson, L.O.1
Zhou, A.X.2
Larsson, E.3
-
67
-
-
78649751904
-
Cyclosporine A administered during reperfusion fails to restore cardioprotection in prediabetic Zucker obese rats in vivo
-
Huhn R, Heinen A, Hollmann MW et al. Cyclosporine A administered during reperfusion fails to restore cardioprotection in prediabetic Zucker obese rats in vivo. Nutr. Metab. Cardiovasc. Dis. 20(10), 706-712 (2010).
-
(2010)
Nutr. Metab. Cardiovasc. Dis.
, vol.20
, Issue.10
, pp. 706-712
-
-
Huhn, R.1
Heinen, A.2
Hollmann, M.W.3
-
68
-
-
84881450484
-
Cyclosporine A at reperfusion fails to reduce infarct size in the in vivo rat heart
-
De PD, Chiari P, Teixeira G et al. Cyclosporine A at reperfusion fails to reduce infarct size in the in vivo rat heart. Basic Res. Cardiol. 108(5), 379 (2013).
-
(2013)
Basic Res. Cardiol.
, vol.108
, Issue.5
, pp. 379
-
-
De Pd Chiari, P.1
Teixeira, G.2
-
69
-
-
0141674628
-
Protection of myocardium by cyclosporin A and insulin: In vitro simulated ischemia study in human myocardium
-
Schneider A, Ad N, Izhar U et al. Protection of myocardium by cyclosporin A and insulin: in vitro simulated ischemia study in human myocardium. Ann. Thorac. Surg. 76(4), 1240-1245 (2003).
-
(2003)
Ann. Thorac. Surg.
, vol.76
, Issue.4
, pp. 1240-1245
-
-
Schneider, A.1
Ad, N.2
Izhar, U.3
-
70
-
-
21644475173
-
Mitochondrial permeability transition pore as a target for cardioprotection in the human heart
-
Shanmuganathan S, Hausenloy DJ, Duchen MR et al. Mitochondrial permeability transition pore as a target for cardioprotection in the human heart. Am. J. Physiol. Heart Circ. Physiol. 289(1), H237-H242 (2005).
-
(2005)
Am. J. Physiol. Heart Circ. Physiol.
, vol.289
, Issue.1
-
-
Shanmuganathan, S.1
Hausenloy, D.J.2
Duchen, M.R.3
-
71
-
-
48249109117
-
Effect of cyclosporine on reperfusion injury in acute myocardial infarction
-
Piot C, Croisille P, Staat P et al. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N. Engl. J. Med. 359(5), 473-481 (2008).
-
(2008)
N. Engl. J. Med.
, vol.359
, Issue.5
, pp. 473-481
-
-
Piot, C.1
Croisille, P.2
Staat, P.3
-
72
-
-
77949309749
-
Effect of cyclosporine on left ventricular remodeling after reperfused myocardial infarction
-
Mewton N, Croisille P, Gahide G et al. Effect of cyclosporine on left ventricular remodeling after reperfused myocardial infarction. J. Am. Coll. Cardiol. 55(12), 1200-1205 (2010).
-
(2010)
J. Am. Coll. Cardiol.
, vol.55
, Issue.12
, pp. 1200-1205
-
-
Mewton, N.1
Croisille, P.2
Gahide, G.3
-
73
-
-
84896546269
-
The effect of cyclosporin-A on peri-operative myocardial injury in adult patients undergoing coronary artery bypass graft surgery: A randomised controlled clinical trial
-
Hausenloy DJ, Kunst G, Boston-Griffiths E et al. The effect of cyclosporin-A on peri-operative myocardial injury in adult patients undergoing coronary artery bypass graft surgery: a randomised controlled clinical trial. Heart 100(7), 544-549 (2013).
-
(2013)
Heart
, vol.100
, Issue.7
, pp. 544-549
-
-
Hausenloy, D.J.1
Kunst, G.2
Boston-Griffiths, E.3
-
74
-
-
4444382387
-
Calcium-calcineurin signaling in the regulation of cardiac hypertrophy
-
Wilkins BJ, Molkentin JD. Calcium-calcineurin signaling in the regulation of cardiac hypertrophy. Biochem. Biophys. Res. Commun. 322(4), 1178-1191 (2004).
-
(2004)
Biochem. Biophys. Res. Commun.
, vol.322
, Issue.4
, pp. 1178-1191
-
-
Wilkins, B.J.1
Molkentin, J.D.2
-
75
-
-
0033921549
-
Cyclosporin A inhibits cardiac hypertrophy and enhances cardiac dysfunction during postinfarction failure in rats
-
Oie E, Bjornerheim R, Clausen OP et al. Cyclosporin A inhibits cardiac hypertrophy and enhances cardiac dysfunction during postinfarction failure in rats. Am. J. Physiol. Heart Circ. Physiol. 278(6), H2115-H2123 (2000).
-
(2000)
Am. J. Physiol. Heart Circ. Physiol.
, vol.278
, Issue.6
-
-
Oie, E.1
Bjornerheim, R.2
Clausen, O.P.3
-
76
-
-
0036895666
-
Effects of the calcineurin dependent signaling pathway inhibition by cyclosporin A on early and late cardiac remodeling following myocardial infarction
-
Youn TJ, Piao H, Kwon JS et al. Effects of the calcineurin dependent signaling pathway inhibition by cyclosporin A on early and late cardiac remodeling following myocardial infarction. Eur. J. Heart Fail. 4(6), 713-718 (2002).
-
(2002)
Eur. J. Heart Fail.
, vol.4
, Issue.6
, pp. 713-718
-
-
Youn, T.J.1
Piao, H.2
Kwon, J.S.3
-
77
-
-
77957842939
-
Cyclophilin D controls mitochondrial pore-dependent Ca(2+) exchange, metabolic flexibility, and propensity for heart failure in mice
-
Elrod JW, Wong R, Mishra S et al. Cyclophilin D controls mitochondrial pore-dependent Ca(2+) exchange, metabolic flexibility, and propensity for heart failure in mice. J. Clin. Invest. 120(10), 3680-3687 (2010).
-
(2010)
J. Clin. Invest.
, vol.120
, Issue.10
, pp. 3680-3687
-
-
Elrod, J.W.1
Wong, R.2
Mishra, S.3
-
78
-
-
80054883388
-
Mitochondrial cyclophilin-D as a potential therapeutic target for post-myocardial infarction heart failure
-
Lim SY, Hausenloy DJ, Arjun S et al. Mitochondrial cyclophilin-D as a potential therapeutic target for post-myocardial infarction heart failure. J. Cell. Mol. Med. 15(11), 2443-2451 (2011).
-
(2011)
J. Cell. Mol. Med.
, vol.15
, Issue.11
, pp. 2443-2451
-
-
Lim, S.Y.1
Hausenloy, D.J.2
Arjun, S.3
-
79
-
-
10244236553
-
The nonimmunosuppressive cyclosporin analogs NIM811 and UNIL025 display nanomolar potencies on permeability transition in brain-derived mitochondria
-
Hansson MJ, Mattiasson G, Mansson R et al. The nonimmunosuppressive cyclosporin analogs NIM811 and UNIL025 display nanomolar potencies on permeability transition in brain-derived mitochondria. J. Bioenerg. Biomembr. 36(4), 407-413 (2004).
-
(2004)
J. Bioenerg. Biomembr.
, vol.36
, Issue.4
, pp. 407-413
-
-
Hansson, M.J.1
Mattiasson, G.2
Mansson, R.3
-
80
-
-
66149129922
-
The cyclophilin inhibitor Debio 025 combined with PEG IFNalph2 significantly reduces viral load in treatment-naive hepatitis C patients
-
Flisiak R, Feinman SV, Jablkowski M et al. The cyclophilin inhibitor Debio 025 combined with PEG IFNalph2 significantly reduces viral load in treatment-naive hepatitis C patients. Hepatology 49(5), 1460-1468 (2009).
-
(2009)
Hepatology
, vol.49
, Issue.5
, pp. 1460-1468
-
-
Flisiak, R.1
Feinman, S.V.2
Jablkowski, M.3
-
81
-
-
77952368170
-
TRO40303, a new cardioprotective compound, inhibits mitochondrial permeability transition
-
Schaller S, Paradis S, Ngoh GA et al. TRO40303, a new cardioprotective compound, inhibits mitochondrial permeability transition. J. Pharmacol. Exp. Ther. 333(3), 696-706 (2010).
-
(2010)
J. Pharmacol. Exp. Ther.
, vol.333
, Issue.3
, pp. 696-706
-
-
Schaller, S.1
Paradis, S.2
Ngoh, G.A.3
-
82
-
-
84872077959
-
Rationale and design of the MITOCARE Study: A Phase II, multicenter, randomized, double-blind, placebo-controlled study to assess the safety and efficacy of TRO40303 for the reduction of reperfusion injury in patients undergoing percutaneous coronary intervention for acute myocardial infarction
-
Atar D, Abitbol JL, Arheden H et al. Rationale and design of the MITOCARE Study: a Phase II, multicenter, randomized, double-blind, placebo-controlled study to assess the safety and efficacy of TRO40303 for the reduction of reperfusion injury in patients undergoing percutaneous coronary intervention for acute myocardial infarction. Cardiology 123(4), 201-207 (2012).
-
(2012)
Cardiology
, vol.123
, Issue.4
, pp. 201-207
-
-
Atar, D.1
Abitbol, J.L.2
Arheden, H.3
-
83
-
-
84856134386
-
Targeting myocardial substrate metabolism in heart failure: Potential for new therapies
-
Ardehali H, Sabbah HN, Burke MA et al. Targeting myocardial substrate metabolism in heart failure: potential for new therapies. Eur. J. Heart Fail. 14(2), 120-129 (2012).
-
(2012)
Eur. J. Heart Fail.
, vol.14
, Issue.2
, pp. 120-129
-
-
Ardehali, H.1
Sabbah, H.N.2
Burke, M.A.3
-
84
-
-
84873413349
-
Mitochondria as a therapeutic target in heart failure
-
Bayeva M, Gheorghiade M, Ardehali H. Mitochondria as a therapeutic target in heart failure. J. Am. Coll. Cardiol. 61(6), 599-610 (2013).
-
(2013)
J. Am. Coll. Cardiol.
, vol.61
, Issue.6
, pp. 599-610
-
-
Bayeva, M.1
Gheorghiade, M.2
Ardehali, H.3
-
85
-
-
76849087987
-
Myocardial remodeling after infarction: The role of myofibroblasts
-
van den Borne SW, Diez J, Blankesteijn WM et al. Myocardial remodeling after infarction: the role of myofibroblasts. Nat. Rev. Cardiol. 7(1), 30-37 (2010).
-
(2010)
Nat. Rev. Cardiol.
, vol.7
, Issue.1
, pp. 30-37
-
-
Van Den Borne, S.W.1
Diez, J.2
Blankesteijn, W.M.3
-
86
-
-
84883592437
-
Mechanisms of altered Ca(2)(+) handling in heart failure
-
Luo M, Anderson ME. Mechanisms of altered Ca(2)(+) handling in heart failure. Circ. Res. 113(6), 690-708 (2013).
-
(2013)
Circ. Res.
, vol.113
, Issue.6
, pp. 690-708
-
-
Luo, M.1
Anderson, M.E.2
-
87
-
-
84880748603
-
Pathological ventricular remodeling: Mechanisms: Part of 2
-
Burchfield JS, Xie M, Hill JA. Pathological ventricular remodeling: mechanisms: part of 2. Circulation 128(4), 388-400 (2013).
-
(2013)
Circulation
, vol.128
, Issue.4
, pp. 388-400
-
-
Burchfield, J.S.1
Xie, M.2
Hill, J.A.3
-
88
-
-
84867738060
-
Mitochondria as a drug target in ischemic heart disease and cardiomyopathy
-
Brookes PS.
-
Walters AM, Porter GA Jr, Brookes PS. Mitochondria as a drug target in ischemic heart disease and cardiomyopathy. Circ. Res. 111(9), 1222-1236 (2012).
-
(2012)
Circ. Res.
, vol.111
, Issue.9
, pp. 1222-1236
-
-
Walters, A.M.1
Porter Jr., G.A.2
-
89
-
-
84864039693
-
Antioxidants and other pharmacological treatments for Friedreich ataxia
-
Kearney M, Orrell RW, Fahey M et al. Antioxidants and other pharmacological treatments for Friedreich ataxia. Cochrane Database Syst. Rev. 4, CD007791 (2012).
-
(2012)
Cochrane Database Syst. Rev.
, vol.4
-
-
Kearney, M.1
Orrell, R.W.2
Fahey, M.3
-
90
-
-
79957764437
-
Mitochondria-targeted antioxidants as therapies
-
Smith RA, Murphy MP. Mitochondria-targeted antioxidants as therapies. Discov. Med. 11(57), 106-114 (2011).
-
(2011)
Discov. Med.
, vol.11
, Issue.57
, pp. 106-114
-
-
Smith, R.A.1
Murphy, M.P.2
-
91
-
-
72449161760
-
Mitochondrial targeting of cyclosporin A enables selective inhibition of cyclophilin-D and enhanced cytoprotection after glucose and oxygen deprivation
-
Malouitre S, Dube H, Selwood D et al. Mitochondrial targeting of cyclosporin A enables selective inhibition of cyclophilin-D and enhanced cytoprotection after glucose and oxygen deprivation. Biochem. J. 425, 137-148 (2010).
-
(2010)
Biochem. J.
, vol.425
, pp. 137-148
-
-
Malouitre, S.1
Dube, H.2
Selwood, D.3
-
92
-
-
84855958407
-
A mitochondrial-targeted cyclosporin A with high binding affinity for cyclophilin D yields improved cytoprotection of cardiomyocytes
-
Dube H, Selwood D, Malouitre S et al. A mitochondrial-targeted cyclosporin A with high binding affinity for cyclophilin D yields improved cytoprotection of cardiomyocytes. Biochem. J. 441(3), 901-907 (2012).
-
(2012)
Biochem. J.
, vol.441
, Issue.3
, pp. 901-907
-
-
Dube, H.1
Selwood, D.2
Malouitre, S.3
-
93
-
-
77955283395
-
Animal and human studies with the mitochondria-targeted antioxidant MitoQ
-
Smith RA, Murphy MP. Animal and human studies with the mitochondria-targeted antioxidant MitoQ. Ann. NY Acad. Sci. 1201, 96-103 (2010).
-
(2010)
Ann. NY Acad. Sci.
, vol.1201
, pp. 96-103
-
-
Smith, R.A.1
Murphy, M.P.2
-
94
-
-
77955792985
-
A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinsons disease
-
Snow BJ, Rolfe FL, Lockhart MM et al. A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinsons disease. Mov. Disord. 25(11), 1670-1674 (2010).
-
(2010)
Mov. Disord.
, vol.25
, Issue.11
, pp. 1670-1674
-
-
Snow, B.J.1
Rolfe, F.L.2
Lockhart, M.M.3
-
95
-
-
77956496245
-
The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a Phase II study of hepatitis C patients
-
Gane EJ, Weilert F, Orr DW et al. The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a Phase II study of hepatitis C patients. Liver Int. 30(7), 1019-1026 (2010).
-
(2010)
Liver Int.
, vol.30
, Issue.7
, pp. 1019-1026
-
-
Gane, E.J.1
Weilert, F.2
Orr, D.W.3
-
96
-
-
84860481279
-
Regulation of mitochondrial processes by protein S-nitrosylation
-
Piantadosi CA. Regulation of mitochondrial processes by protein S-nitrosylation. Biochim. Biophys. Acta 1820(6), 712-721 (2012).
-
(2012)
Biochim. Biophys. Acta
, vol.1820
, Issue.6
, pp. 712-721
-
-
Piantadosi, C.A.1
-
97
-
-
67649757115
-
A mitochondria-targeted S-nitrosothiol modulates respiration, nitrosates thiols, and protects against ischemia-reperfusion injury
-
Prime TA, Blaikie FH, Evans C et al. A mitochondria-targeted S-nitrosothiol modulates respiration, nitrosates thiols, and protects against ischemia-reperfusion injury. Proc. Natl Acad. Sci. USA 106(26), 10764-10769 (2009).
-
(2009)
Proc. Natl Acad. Sci. USA
, vol.106
, Issue.26
, pp. 10764-10769
-
-
Prime, T.A.1
Blaikie, F.H.2
Evans, C.3
-
98
-
-
84880253528
-
Cardioprotection by S-nitrosation of a cysteine switch on mitochondrial complex i
-
Chouchani ET, Methner C, Nadtochiy SM et al. Cardioprotection by S-nitrosation of a cysteine switch on mitochondrial complex I. Nat. Med. 19(6), 753-759 (2013).
-
(2013)
Nat. Med.
, vol.19
, Issue.6
, pp. 753-759
-
-
Chouchani, E.T.1
Methner, C.2
Nadtochiy, S.M.3
-
99
-
-
4544370680
-
Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury
-
Zhao K, Zhao GM, Wu D et al. Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury. J. Biol. Chem. 279(33), 34682-34690 (2004).
-
(2004)
J. Biol. Chem.
, vol.279
, Issue.33
, pp. 34682-34690
-
-
Zhao, K.1
Zhao, G.M.2
Wu, D.3
-
100
-
-
84881090284
-
The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin
-
Birk AV, Liu S, Soong Y et al. The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin. J. Am. Soc. Nephrol. 24(8), 1250-1261 (2013).
-
(2013)
J. Am. Soc. Nephrol.
, vol.24
, Issue.8
, pp. 1250-1261
-
-
Birk, A.V.1
Liu, S.2
Soong, Y.3
-
101
-
-
34247209532
-
Potent mitochondria-targeted peptides reduce myocardial infarction in rats
-
Cho J, Won K, Wu D et al. Potent mitochondria-targeted peptides reduce myocardial infarction in rats. Coron. Artery Dis. 18(3), 215-220 (2007).
-
(2007)
Coron. Artery Dis.
, vol.18
, Issue.3
, pp. 215-220
-
-
Cho, J.1
Won, K.2
Wu, D.3
-
102
-
-
84875149020
-
Reduction of ischemia/reperfusion injury with bendavia, a mitochondria-targeting cytoprotective peptide
-
Kloner RA, Hale SL, Dai W et al. Reduction of ischemia/reperfusion injury with bendavia, a mitochondria-targeting cytoprotective peptide. J. Am. Heart Assoc. 1(3), e001644 (2012).
-
(2012)
J. Am. Heart Assoc.
, vol.1
, Issue.3
-
-
Kloner, R.A.1
Hale, S.L.2
Dai, W.3
-
103
-
-
79959525058
-
Mitochondrial targeted antioxidant peptide ameliorates hypertensive cardiomyopathy
-
Dai DF, Chen T, Szeto H et al. Mitochondrial targeted antioxidant peptide ameliorates hypertensive cardiomyopathy. J. Am. Coll. Cardiol. 58(1), 73-82 (2011).
-
(2011)
J. Am. Coll. Cardiol.
, vol.58
, Issue.1
, pp. 73-82
-
-
Dai, D.F.1
Chen, T.2
Szeto, H.3
-
104
-
-
79954694973
-
Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure
-
Dai DF, Johnson SC, Villarin JJ et al. Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure. Circ. Res. 108(7), 837-846 (2011).
-
(2011)
Circ. Res.
, vol.108
, Issue.7
, pp. 837-846
-
-
Dai, D.F.1
Johnson, S.C.2
Villarin, J.J.3
-
105
-
-
84875422028
-
Rationale and design of the EMBRACE STEMI study: A Phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction
-
Chakrabarti AK, Feeney K, Abueg C et al. Rationale and design of the EMBRACE STEMI study: a Phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction. Am. Heart J. 165(4), 509-514 (2013).
-
(2013)
Am. Heart J.
, vol.165
, Issue.4
, pp. 509-514
-
-
Chakrabarti, A.K.1
Feeney, K.2
Abueg, C.3
-
107
-
-
79958172986
-
Preconditioning involves selective mitophagy mediated by Parkin and p62/SQSTM1
-
Huang C, Andres AM, Ratliff EP et al. Preconditioning involves selective mitophagy mediated by Parkin and p62/SQSTM1. PLoS ONE 6(6), e20975 (2011).
-
(2011)
PLoS ONE
, vol.6
, Issue.6
-
-
Huang, C.1
Andres, A.M.2
Ratliff, E.P.3
-
108
-
-
84913546616
-
Mitophagy is required for acute cardioprotection by simvastatin
-
doi:10.1089/ars.2013.5416 Epub ahead of print
-
Andres AM, Hernandez G, Lee P et al. Mitophagy is required for acute cardioprotection by simvastatin. Antioxid. Redox Signal. doi:10.1089/ars.2013. 5416 (2013) (Epub ahead of print).
-
(2013)
Antioxid. Redox Signal.
-
-
Andres, A.M.1
Hernandez, G.2
Lee, P.3
-
109
-
-
84155180848
-
P53-TIGAR axis attenuates mitophagy to exacerbate cardiac damage after ischemia
-
Hoshino A, Matoba S, Iwai-Kanai E et al. p53-TIGAR axis attenuates mitophagy to exacerbate cardiac damage after ischemia. J. Mol. Cell. Cardiol. 52(1), 175-184 (2012).
-
(2012)
J. Mol. Cell. Cardiol.
, vol.52
, Issue.1
, pp. 175-184
-
-
Hoshino, A.1
Matoba, S.2
Iwai-Kanai, E.3
-
110
-
-
84872283780
-
Parkin protein deficiency exacerbates cardiac injury and reduces survival following myocardial infarction
-
Kubli DA, Zhang X, Lee Y et al. Parkin protein deficiency exacerbates cardiac injury and reduces survival following myocardial infarction. J. Biol. Chem. 288(2), 915-926 (2013).
-
(2013)
J. Biol. Chem.
, vol.288
, Issue.2
, pp. 915-926
-
-
Kubli, D.A.1
Zhang, X.2
Lee, Y.3
-
111
-
-
84876889535
-
Loss of PINK1 increases the hearts vulnerability to ischemia-reperfusion injury
-
Siddall HK, Yellon DM, Ong SB et al. Loss of PINK1 increases the hearts vulnerability to ischemia-reperfusion injury. PLoS ONE 8(4), e62400 (2013).
-
(2013)
PLoS ONE
, vol.8
, Issue.4
-
-
Siddall, H.K.1
Yellon, D.M.2
Ong, S.B.3
-
112
-
-
84880673845
-
Pharmacological approaches to restore mitochondrial function
-
Andreux PA, Houtkooper RH, Auwerx J. Pharmacological approaches to restore mitochondrial function. Nat. Rev. Drug Discov. 12(6), 465-483 (2013).
-
(2013)
Nat. Rev. Drug Discov.
, vol.12
, Issue.6
, pp. 465-483
-
-
Andreux, P.A.1
Houtkooper, R.H.2
Auwerx, J.3
-
113
-
-
84883795966
-
Mitochondrial dynamics in the adult cardiomyocytes: Which roles for a highly specialized cell Front
-
Piquereau J, Caffin F, Novotova M et al. Mitochondrial dynamics in the adult cardiomyocytes: which roles for a highly specialized cell Front. Physiol. 4, 102 (2013).
-
(2013)
Physiol.
, vol.4
, Issue.102
-
-
Piquereau, J.1
Caffin, F.2
Novotova, M.3
-
114
-
-
84879858842
-
Mitochondrial dynamics in cardiovascular health and disease
-
Ong SB, Hall AR, Hausenloy DJ. Mitochondrial dynamics in cardiovascular health and disease. Antioxid. Redox Signal. 19(4), 400-414 (2013).
-
(2013)
Antioxid. Redox Signal.
, vol.19
, Issue.4
, pp. 400-414
-
-
Ong, S.B.1
Hall, A.R.2
Hausenloy, D.J.3
-
115
-
-
77952236126
-
Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury
-
Ong SB, Subrayan S, Lim SY et al. Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury. Circulation 121(18), 2012-2022 (2010).
-
(2010)
Circulation
, vol.121
, Issue.18
, pp. 2012-2022
-
-
Ong, S.B.1
Subrayan, S.2
Lim, S.Y.3
-
116
-
-
84255192658
-
Cardiomyocyte deletion of mitofusin-1 leads to mitochondrial fragmentation and improves tolerance to ROS-induced mitochondrial dysfunction and cell death
-
Papanicolaou KN, Ngoh GA, Dabkowski ER et al. Cardiomyocyte deletion of mitofusin-1 leads to mitochondrial fragmentation and improves tolerance to ROS-induced mitochondrial dysfunction and cell death. Am. J. Physiol. Heart Circ. Physiol. 302(1), H167-H179 (2012).
-
(2012)
Am. J. Physiol. Heart Circ. Physiol.
, vol.302
, Issue.1
-
-
Papanicolaou, K.N.1
Ngoh, G.A.2
Dabkowski, E.R.3
|